scholarly journals Abstract No. 455 Radiation doses with increased experience in prostatic artery embolization for benign prostatic hypertrophy: a single-institution series

2021 ◽  
Vol 32 (5) ◽  
pp. S112-S113
Author(s):  
V. Acharya ◽  
T. Pennix ◽  
H. Clode ◽  
K. Shah ◽  
H. Jalaeian ◽  
...  
Keyword(s):  
Benign Prostatic Hypertrophy ◽  
Prostatic Hypertrophy ◽  
Radiation Doses ◽  
Single Institution ◽  
Artery Embolization ◽  
Prostatic Artery Embolization ◽  
Prostatic Artery

RADIATION DOSES TO ANAESTHETISTS DURING PROSTATIC ARTERY EMBOLIZATION INTERVENTIONAL PROCEDURES

2019 ◽  
Vol 185 (2) ◽  
pp. 196-200
Author(s):  
W J Garzón ◽  
H J Khoury
Keyword(s):  
Radiation Doses ◽  
Dose Equivalent ◽  
Dose Limit ◽  
Artery Embolization ◽  
Prostatic Artery Embolization ◽  
Protection Measures ◽  
Oblique Projections ◽  
Reference Hospital ◽  
The City ◽  
Prostatic Artery

Abstract The objective of this study was to assess the radiation doses received by anaesthetists from prostatic artery embolization (PAE) procedures. Ten PAE procedures conducted in a reference hospital in the city of Recife, Brazil were investigated. Occupational dosimetry was performed using thermoluminescent dosemeters which were located next to the eyes, close to the thyroid (over the shielding), on the thorax (under the apron), on the wrist and on the feet of the physician’s body. The results showed that the anaesthetist’s feet received the highest doses followed by the eyes and the hands. In some complex PAE procedures the doses received by anaesthetists on the lens of the eyes and the effective dose were higher than those received by the main operator due to the anaesthetist’s close position to the patient’s table and the use of oblique projections. The personal dose equivalent Hp(3) per procedure for the anaesthetist’s right eyebrow ranged from 20.2 μSv to 568.3 μSv. This result shows that anaesthetists assisting PAE procedures can exceeds the annual eye lens dose limit of 20 mSv recommended by the ICRP with only one procedure per week if radiation protection measures are not implemented during procedures.

scholarly journals Prostatic artery embolization (PAE) for prostatic origin bleeding in the context of prostate malignancy

2019 ◽  
Vol 8 (6) ◽  
pp. 205846011984606 ◽  
Author(s):  
Charles R Tapping ◽  
Jeremy Crew ◽  
Andrew Proteroe ◽  
Phil Boardman
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Metastatic Prostate Cancer ◽  
Benign Prostatic Hypertrophy ◽  
Artery Embolization ◽  
Prostatic Artery Embolization ◽  
Prostate Artery Embolization ◽  
Prostatic Artery

Prostate artery embolization (PAE) has been shown to be beneficial in treating men with benign prostatic hypertrophy (BPH). Here we describe treating four patients with prostate cancer (two with organ-confined and two with metastatic prostate cancer) with prostatic bleeding with PAE. Patients had other causes of hematuria excluded and were followed up at 3, 12, and 18 months after PAE. All four cases were technically successful and all cases of hematuria had resolved by the three-month follow-up (100%). There was one case of recurrence at 13 months after PAE which was successfully treated. PAE is useful for controlling significant prostatic bleeding in patients with prostate cancer and improves quality of life. Patients may, however, need repeated treatments to control the bleeding.

scholarly journals Prostatic Artery Embolization (PAE) and Transurethral Resection of the Prostate (TURP) have a Differential Impact on Lower Urinary Tract Symptoms (LUTS): Retrospective Analysis of the Multicentre UK-ROPE (UK Register of Prostate Embolization) Study

2021 ◽  
Author(s):  
Ganesh Vigneswaran ◽  
Drew Maclean ◽  
Mohammed Hadi ◽  
Benjamin Maher ◽  
Sachin Modi ◽  
...  
Keyword(s):  
Retrospective Analysis ◽  
Transurethral Resection ◽  
Artery Embolization ◽  
Prostatic Artery Embolization ◽  
Voiding Symptoms ◽  
Significant Difference ◽  
Student’S T ◽  
The Uk ◽  
And Storage ◽  
Prostatic Artery

Abstract Purpose To compare the relative IPSS (International Prostate Symptom Score) improvement in storage and voiding symptoms between prostatic artery embolization (PAE) and transurethral resection of the prostate (TURP). Method Retrospective analysis of the UK-ROPE (UK Register of Prostate Embolization) multicentre database was conducted with inclusion of all patients with full IPSS questionnaire score data. The voiding and storage subscore improvement was compared between interventions. Student’s t-test (paired and unpaired) and ANOVA (Analysis of variance) were used to identify significant differences between the groups. Results 146 patients (121 PAE, 25 TURP) were included in the analysis. Storage symptoms were more frequently the most severe symptom (‘storage’ in 75 patients vs ‘voiding’ in 17 patients). Between groups, no significant difference was seen in raw storage subscore improvement (TURP 4.9 vs PAE 4.2; p = 0.34) or voiding subscore improvement (TURP 8.4 vs PAE 6.7; p = 0.1). ANOVA demonstrated a greater proportionate reduction (relative to total IPSS) towards voiding symptoms in the TURP group (27.3% TURP vs 9.9% PAE, p = 0.001). Conclusion Although both TURP and PAE improve voiding symptoms more than storage, a significantly larger proportion of total symptom reduction is due to voiding in the TURP cohort, with PAE providing a more balanced improvement between voiding and storage.

Sign in / Sign up

Export Citation Format

Share Document